CryoPort, Inc. (NASDAQ:CYRX) announced its quarterly earnings results on Tuesday. The company reported ($0.08) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.09) by $0.01, Morningstar.com reports. The business had revenue of $2.92 million during the quarter, compared to the consensus estimate of $2.84 million. CryoPort had a negative net margin of 137.99% and a negative return on equity of 104.79%.

Shares of CryoPort (NASDAQ:CYRX) traded up 3.17% during mid-day trading on Wednesday, hitting $6.83. 298,458 shares of the stock were exchanged. The stock’s market cap is $163.75 million. The company has a 50-day moving average of $5.51 and a 200 day moving average of $3.73. CryoPort has a one year low of $1.80 and a one year high of $7.18.

A number of analysts have recently issued reports on the stock. Cowen and Company raised their price target on shares of CryoPort from $5.50 to $7.50 and gave the stock an “outperform” rating in a report on Wednesday. Janney Montgomery Scott raised their price target on shares of CryoPort from $8.00 to $10.00 and gave the stock a “buy” rating in a report on Wednesday. Needham & Company LLC raised their price target on shares of CryoPort from $3.50 to $4.50 and gave the stock a “buy” rating in a report on Thursday, June 1st. Finally, ValuEngine upgraded shares of CryoPort from a “sell” rating to a “hold” rating in a report on Thursday, May 11th.

COPYRIGHT VIOLATION WARNING: “CryoPort, Inc. (CYRX) Posts Earnings Results, Beats Expectations By $0.01 EPS” was first published by Watch List News and is the property of of Watch List News. If you are accessing this article on another site, it was illegally stolen and reposted in violation of United States and international copyright & trademark legislation. The correct version of this article can be accessed at https://www.watchlistnews.com/cryoport-inc-cyrx-posts-earnings-results-beats-expectations-by-0-01-eps/1466382.html.

CryoPort Company Profile

Cryoport, Inc (Cryoport) is a provider of cryogenic logistics solutions to the life sciences industry through its purpose-built packaging, information technology and specialized cold chain logistics expertise. The Company provides logistics solutions for biologic materials, such as immunotherapies, stem cells, chimeric antigen receptors (CAR)-T cells, and reproductive cells for clients.

Receive News & Ratings for CryoPort Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CryoPort Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.